4//SEC Filing
Frohlich Tom 4
Accession 0001209191-23-009769
CIK 0001435049other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:40 PM ET
Size
9.5 KB
Accession
0001209191-23-009769
Insider Transaction Report
Form 4
Frohlich Tom
Chief Business Officer
Transactions
- Exercise/Conversion
Common Stock
2023-02-10+6,803→ 154,477 total - Sale
Common Stock
2023-02-10$23.75/sh−3,700$87,869→ 150,777 total - Exercise/Conversion
Restricted Stock Units
2023-02-10−6,803→ 6,801 totalExp: 2024-02-10→ Common Stock (6,803 underlying)
Footnotes (4)
- [F1]Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
- [F2]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
- [F3]Each RSU represents a contingent right to receive one share of Issuer's common stock.
- [F4]The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on February 10, 2022, until fully vested, subject to the reporting person's provision of service to the Issuer on each vesting date.
Documents
Issuer
CHINOOK THERAPEUTICS, INC.
CIK 0001435049
Entity typeother
Related Parties
1- filerCIK 0001823925
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 4:40 PM ET
- Size
- 9.5 KB